These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 15919406)
1. Progestin effects on epidermal growth factor receptor (EGFR) endometrial expression in normal and hyperplastic endometrium. Jasonni VM; La Marca A; Santini D Int J Gynaecol Obstet; 2005 Jun; 89(3):297-8. PubMed ID: 15919406 [No Abstract] [Full Text] [Related]
2. [The pathogenetic basis for using antiestrogens in treating patients with hyperplastic processes of the endometrium in the postmenopause]. Vysotskiĭ MM; Krasnova IA; Kostyleva OI; Eremin VL Akush Ginekol (Mosk); 1993; (6):46-9. PubMed ID: 8311159 [TBL] [Abstract][Full Text] [Related]
3. The effect of progestin on factors influencing growth and invasion of endometrial carcinoma. Jasonni VM; Bulletti C; Balducci M; Naldi S; Martinelli G; Galassi A; Flamigni C Ann N Y Acad Sci; 1991; 622():463-8. PubMed ID: 2064202 [TBL] [Abstract][Full Text] [Related]
4. Hysteroscopic pictures following danazol therapy in endometrial hyperplasia. Busacca M; Luchini S; Molinari MA; Tonta A; Marelli G Acta Eur Fertil; 1987; 18(3):197-201. PubMed ID: 3439406 [TBL] [Abstract][Full Text] [Related]
5. Danazol reverses endometrial hyperplasia to normal endometrium. Bulletti C; Jasonni VM; Tabanelli S; Balducci M; Fuschini G; Flamigni C Acta Eur Fertil; 1987; 18(3):185-7. PubMed ID: 3439404 [TBL] [Abstract][Full Text] [Related]
6. Comparison of antiproliferative effects of metformine and progesterone on estrogen-induced endometrial hyperplasia in rats. Tas M; Kutuk MS; Serin IS; Ozgun MT; Oner G; Ozturk F Gynecol Endocrinol; 2013 Apr; 29(4):311-4. PubMed ID: 23305503 [TBL] [Abstract][Full Text] [Related]
7. [The effect of danazol and tamoxifen on endometrial hyperplasia]. Soh E Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1612-22. PubMed ID: 2730056 [TBL] [Abstract][Full Text] [Related]
8. Preliminary report on the use of danazol in the treatment of endometrial adenomatous hyperplasia. Terakawa N; Inoue M; Shimizu I; Ikegami H; Mizutani T; Sakata M; Tanizawa O; Matsumoto K Cancer; 1988 Dec; 62(12):2618-21. PubMed ID: 3191463 [TBL] [Abstract][Full Text] [Related]
9. [Clinical application of the results of studies of hormonal receptors in persistent hyperplastic transformation of the endometrium]. Vikhliaeva EM; Shchedrina RN; Alekseeva ML; Minina LS; Novikov EA Akush Ginekol (Mosk); 1988 Nov; (11):26-30. PubMed ID: 3239678 [No Abstract] [Full Text] [Related]
10. [Epidermal growth factor receptor expression and epidermal growth factor blood plasma content in simple and complex endometrial hyperplasia]. Dznelashvili N; Kasradze D; Tavartkiladze A; Mariamidze A Georgian Med News; 2014 Jan; (226):59-65. PubMed ID: 24523335 [TBL] [Abstract][Full Text] [Related]
11. In vitro binding of progesterone by the human endometrium during the menstrual cycle and by hyperplastic, atrophic, and carcinomatous endometrium. Haukkamaa M; Karjalainen O; Luukkainen T Am J Obstet Gynecol; 1971 Sep; 111(2):205-10. PubMed ID: 5098589 [No Abstract] [Full Text] [Related]
12. Direct effect of danazol on endometrial hyperplasia in adenomyotic women: treatment with danazol containing intrauterine device. Tamaoka Y; Orikasa H; Sumi Y; Sakakura K; Kamei K; Nagatani M; Ezawa S Hum Cell; 2000 Sep; 13(3):127-33. PubMed ID: 11197774 [TBL] [Abstract][Full Text] [Related]
13. Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial cancer, endometrial hyperplasia, and normal endometrium. Orejuela FJ; Ramondetta LM; Smith J; Brown J; Lemos LB; Li Y; Hollier LM Gynecol Oncol; 2005 May; 97(2):483-8. PubMed ID: 15863148 [TBL] [Abstract][Full Text] [Related]
14. Regulation of plasminogen activator inhibitor 1 expression by interaction of epidermal growth factor with progestin during decidualization of human endometrial stromal cells. Lockwood CJ Am J Obstet Gynecol; 2001 Apr; 184(5):798-804; discussion 804-5. PubMed ID: 11303186 [TBL] [Abstract][Full Text] [Related]
15. Effects of hormone therapy on the endometrium. Deligdisch L Mod Pathol; 1993 Jan; 6(1):94-106. PubMed ID: 8426860 [TBL] [Abstract][Full Text] [Related]
16. Steroid receptors in normal, hyperplastic and malignant human endometria. Vihko R; Jänne O; Kauppila A Ann Clin Res; 1980 Oct; 12(5):208-15. PubMed ID: 7015983 [TBL] [Abstract][Full Text] [Related]
17. Postmenopausal endometrial hyperplasia: role of danazol therapy. Mariani L; Sedati A; Giovinazzi R; Sindico R; Atlante G Int J Gynaecol Obstet; 1994 Feb; 44(2):155-9. PubMed ID: 7911101 [TBL] [Abstract][Full Text] [Related]
18. Clinical effects of danazol on endometrial hyperplasia in menopausal and postmenopausal women. Soh E; Sato K Cancer; 1990 Sep; 66(5):983-8. PubMed ID: 2386926 [TBL] [Abstract][Full Text] [Related]
19. [The endometrium under the effects of hormone replacement therapy in menopause with percutaneous estradiol and low-dose micronized progesterone]. Philippe E; Faguer B; Engelman A; Charpin C; Loubière R; de Mascarel A; Leduc F; Dupin P; Hemet J; Vauzelle JL Pathologica; 1993; 85(1099):475-87. PubMed ID: 8127629 [TBL] [Abstract][Full Text] [Related]
20. Sex steroid receptors in endometrial hyperplasia and neoplasia [proceedings]. Gurpide E Acta Cytol; 1980; 24(6):483-5. PubMed ID: 6934674 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]